Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/7894
Title: | Biologic agents and tuberculosis | Authors: | Claudia Dobler | Issue Date: | 27-Apr-2017 | Journal: | Tuberculosis and Nontuberculous Mycobacterial Infections | Abstract: | In recent years, the market of biopharmaceuticals has been growing at a fast pace due to increased availability of targets for biologic agents, approval of biologic agents for new and expanded indications, and increased use of these medications. Biopharmaceuticals, also known as biologic products or agents, biologics, or biologicals, are drugs that are produced through biological processes rather than chemical synthesis. These include recombinant proteins, monoclonal and polyclonal antibodies, peptides, antisense oligonucleotides, therapeutic genes, and recombinant and DNA vaccines. Biopharmaceuticals usually require infusion or injection rather than oral application. |
Appears in Sites: | Publication workflow Queensland Health Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.